Market & Regulation
Demis Hassabis on AGI and AI in Medicine
The Rundown AIhigh confidence
Why it matters
- →Hassabis's prediction sets a timeline for AGI, focusing research efforts.
- →AI's role in drug discovery could accelerate medical breakthroughs.
- →Philosophical applications of AI could redefine our understanding of reality.
Demis Hassabis, CEO of Google DeepMind, shared his insights on the future of Artificial General Intelligence (AGI) and AI's role in medicine. He anticipates AGI could be realized by 2030, though challenges like understanding world physics and memory remain. Hassabis sees AI as pivotal in drug discovery, with oncology and immunology as initial focus areas. He also envisions AI aiding in philosophical explorations about reality and human nature. This outlook underscores AI's potential to revolutionize both scientific research and philosophical understanding.
Read originalThe story around this
Earlier coverage that leads up to this article, and what followed. Lines connect each piece to the closest one after it, converging here.
More in Market & Regulation
© TechCrunch AIMarket & Regulationother
Judge allows NAACP lawsuit over xAI pollution to proceed
xAI's attempt to dismiss the NAACP's Clean Air Act lawsuit failed after a federal judge ruled that its gas turbines are not exempt mobile sources and that plaintiffs have standing. This legal setback confirms that AI infrastructure operators cannot bypass environmental permitting by classifying heavy industrial equipment as temporary or mobile. The ruling forces xAI to face scrutiny over air quality impacts at its Colossus data center, setting a precedent for how large-scale compute facilities are regulated under existing environmental laws.
TechCrunch AI
© TechCrunch AI